RT Journal
A1 Hart CE, Siegel B
T1 MEdication discount program
JF JAMA
JO JAMA
YR 2012
FD July 18
VO 308
IS 3
SP 237
OP 238
DO 10.1001/jama.2012.6622
UL http://dx.doi.org/10.1001/jama.2012.6622
AB 
The article stated that “participating institutions may dispense the discounted drugs to patients who are uninsured, on marginal incomes, or without another source for preventive and primary care services. The concern is that entities may be buying discounted drugs, giving these medications to different patients, and charging insurers or Medicare full price.” These statements suggest that discounted pricing is available only for low-income or uninsured patients and that insurance companies and Medicare may be overpaying 340B providers. Both assertions are incorrect.